| Literature DB >> 11500501 |
S G Schiffer1, S Foley, A Kaffashan, X Hronowski, A E Zichittella, C Y Yeo, K Miatkowski, H B Adkins, B Damon, M Whitman, D Salomon, M Sanicola, K P Williams.
Abstract
O-linked fucose modification is rare and has been shown to occur almost exclusively within epidermal growth factor (EGF)-like modules. We have found that the EGF-CFC family member human Cripto-1 (CR) is modified with fucose and through a combination of peptide mapping, mass spectrometry, and sequence analysis localized the site of attachment to Thr-88. The identification of a fucose modification on human CR within its EGF-like domain and the presence of a consensus fucosylation site within all EGF-CFC family members suggest that this is a biologically important modification in CR, which functionally distinguishes it from the EGF ligands that bind the type 1 erbB growth factor receptors. A single CR point mutation, Thr-88 --> Ala, results in a form of the protein that is not fucosylated and has substantially weaker activity in cell-based CR/Nodal signaling assays, indicating that fucosylation is functionally important for CR to facilitate Nodal signaling.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11500501 DOI: 10.1074/jbc.M104774200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157